Caitlin John LLC Takes $834,000 Position in HCA Healthcare, Inc. $HCA

Caitlin John LLC purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 2,139 shares of the company’s stock, valued at approximately $834,000.

Several other large investors have also modified their holdings of HCA. Nomura Asset Management Co. Ltd. boosted its holdings in HCA Healthcare by 6.2% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock valued at $29,990,000 after acquiring an additional 3,724 shares during the period. Sunbelt Securities Inc. lifted its position in shares of HCA Healthcare by 171.7% during the first quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock worth $2,954,000 after purchasing an additional 3,945 shares during the last quarter. Liberty Wealth Management LLC bought a new position in shares of HCA Healthcare in the fourth quarter worth about $1,905,000. Arrowstreet Capital Limited Partnership lifted its holdings in HCA Healthcare by 11.9% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock valued at $1,078,966,000 after buying an additional 245,887 shares in the last quarter. Finally, Sei Investments Co. grew its stake in HCA Healthcare by 27.5% in the 1st quarter. Sei Investments Co. now owns 467,796 shares of the company’s stock worth $221,380,000 after acquiring an additional 100,764 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA stock opened at $419.19 on Friday. The stock’s 50-day moving average is $400.24 and its 200 day moving average is $441.63. HCA Healthcare, Inc. has a 1-year low of $353.99 and a 1-year high of $556.52. The company has a market cap of $90.75 billion, a P/E ratio of 14.03, a PEG ratio of 1.48 and a beta of 1.10.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating the consensus estimate of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The business had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. During the same period in the prior year, the firm posted $6.84 earnings per share. The company’s quarterly revenue was up 8.7% on a year-over-year basis. On average, analysts anticipate that HCA Healthcare, Inc. will post 29.42 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be given a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s payout ratio is currently 10.45%.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on HCA shares. Wall Street Zen cut HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. Robert W. Baird lowered their target price on HCA Healthcare from $396.00 to $393.00 and set a “neutral” rating for the company in a report on Monday, July 27th. Sanford C. Bernstein restated a “market perform” rating on shares of HCA Healthcare in a report on Wednesday, July 15th. JPMorgan Chase & Co. dropped their target price on shares of HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating on the stock in a report on Thursday, August 20th. Finally, Oppenheimer reduced their price target on shares of HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a report on Monday, July 27th. Fourteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and an average price target of $462.64.

HCA Healthcare Company Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.